Expressing support for the designation of May 17, 2025, as "Necrotizing Enterocolitis Awareness Day".
H. Res. 429 is a simple House resolution expressing support for designating May 17, 2025, as “Necrotizing Enterocolitis Awareness Day.” The resolution does not create a new program, mandate, or funding stream. Instead, it uses congressional recognition to highlight necrotizing enterocolitis (NEC), a severe and often fatal intestinal disease that primarily affects premature infants and other medically fragile newborns.
The resolution’s findings describe NEC as a leading cause of death among hospitalized premature infants after two weeks of age, note the high medical costs associated with treatment, and emphasize the importance of prevention through breast milk or pasteurized donor human milk when mother’s milk is unavailable. It also highlights the need for more data, family-centered care, and attention to racial disparities, stating that Black infants are disproportionately affected and die from NEC at higher rates than White infants. The measure is framed as an awareness and education resolution rather than a regulatory or appropriations bill.
Because this is a commemorative resolution, its direct legal impact on state or federal law is minimal. It does not amend the U.S. Code, alter state statutes, or impose requirements on hospitals, insurers, or families. Its practical effect is symbolic: it encourages public awareness of NEC, supports advocacy around prevention and research, and may help elevate attention to neonatal care practices, donor milk access, and disparities in infant health outcomes.
The available context suggests broadly supportive sentiment. The resolution was introduced by Representatives Thompson of California, Kiley, and McGarvey, indicating bipartisan sponsorship, and the text itself is strongly affirmative in tone toward awareness, prevention, and family-centered care. There are no recorded committee transcripts or votes showing opposition, and the measure’s commemorative nature typically attracts consensus rather than controversy.
No specific points of contention are documented in the provided materials. The resolution does, however, make policy-relevant statements that could draw discussion in other settings, including its emphasis that formula does not protect against NEC in medically fragile infants, its support for breast milk and pasteurized donor milk, and its callout of racial disparities affecting Black infants. Those issues could be debated by stakeholders in neonatal care, breastfeeding advocacy, donor milk access, and health equity, but no formal opposition is shown here.